Literature DB >> 7061569

Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.

N Saijo, E Shimizu, N Irimajiri, A Ozaki, K Kimura, T Takizawa, H Niitani.   

Abstract

To clarify the contribution of ADCC and NK activities to host immune response against cancer, the characteristics of cells mediating these activities were examined in the peripheral blood lymphocytes of normal volunteers, and the changes of these activities were also evaluated in patients with lung cancer and metastatic pulmonary tumors before and after chemotherapy. OAT cells derived from small cell carcinoma of the lung and K-562 cells derived from erythroleukemia were used as target cells of ADCC and/or NK assay. ADCC and NK activities were not changed according to age, sex, and blood type. Mild and marked personal difference were observed in ADCC and NK activity, respectively. These activities were also influenced by environment. ADCC and NK activities of normal adult volunteers were diversely correlated at the coefficient of gamma-0.426. NK activities were high against K-562 and CCRF-CEM cells, and low against BALL and OAT cells. NK activity against K-562 cells was strongly inhibited by K-562 or CCRF-CEM cells with high NK sensitivity, on the other hand, it was slightly inhibited by OAT and BALL cells with low NK sensitivity. NK activity against OAT cells was strongly inhibited by OAT, K-562 and CCRF-CEM cells, but not inhibited by BALL cells. The effector cells mediating NK activity were identified as non-adherent, E-receptor-positive, Fc-receptor-positive small lymphocytes. NK activity was not decreased before chemotherapy in patients with stage III primary lung cancer and metastatic pulmonary tumors. It was decreased only in patients of bad performance status, and it was significantly decreased in all patients after chemotherapy. ADCC also exhibited the tendency to decrease after chemotherapy in tumor-bearing patients. The recovery of NK-activity after chemotherapy well correlated with the effect of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7061569     DOI: 10.1007/bf00411340

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  51 in total

1.  Search for specificity in natural cell-mediated cytotoxicity.

Authors:  M Takasugi; M Hardiwidjaja; R McAllister; M Peer
Journal:  J Natl Cancer Inst       Date:  1979-12       Impact factor: 13.506

2.  Positive correlation between the levels of natural killer cells and the in vivo resistance to syngeneic tumor transplants as influenced by various routes of administration of Corynebacterium parvum bacteria.

Authors:  E Ojo
Journal:  Cell Immunol       Date:  1979-06       Impact factor: 4.868

3.  Natural cytotoxic reactivity of human lymphocyte subpopulations.

Authors:  M R Potter; M Moore
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

4.  Spontaneous in vitro cytotoxicity against autochthonous human melanoma cells.

Authors:  B Mukherji; A Flowers; L Rothman; L Nathanson
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

5.  Human "null" cells mediating antibody-dependent cellular cytotoxicity express T lymphocyte differentiation antigens.

Authors:  C M Balch; E W Ades; M R Loken; S L Shore
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

6.  Linoleic acid inhibition of naturally occurring lymphocytotoxicity to breast cancer-derived cells measured by a chromium-51 release assay.

Authors:  C P Samlaska
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

7.  Rapid in vivo assay of mouse natural killer cell activity.

Authors:  C Riccardi; P Puccetti; A Santoni; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1979-10       Impact factor: 13.506

8.  Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum(II).

Authors:  E S Kleinerman; L A Zwelling; A V Muchmore
Journal:  Cancer Res       Date:  1980-09       Impact factor: 12.701

9.  An analysis of conditions allowing Corynebacterium parvum to cause either augmentation or inhibition of natural killer cell activity against tumor cells in mice.

Authors:  E Ojo; O Haller; A Kimura; H Wigzell
Journal:  Int J Cancer       Date:  1978-04-15       Impact factor: 7.396

10.  Target selectivity of interferon-induced human killer lymphocytes related to their Fc receptor expression.

Authors:  M G Masucci; G Masucci; E Klein; W Berthold
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  7 in total

1.  In vivo augmentation of the cytotoxicity of spleen lymphocytes against syngeneic B-16 melanoma cells and the suppression of the artificial metastases in C57BL/6 mice by subcutaneous multiple injections of high dose human recombinant interleukin-2 (rIL-2).

Authors:  N Saijo; A Ozaki; H Nakano; M Sakurai; H Takahashi; Y Sasaki; A Hoshi
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

2.  The analysis of cytostatic activity of human peripheral blood granulocytes and its augmentation with Nocardia rubra cell wall skeleton (N-CWS).

Authors:  E Shimizu; N Saijo; M Shibuya; T Takizawa; A Hoshi
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

3.  [Immune status of patients with bronchial cancer].

Authors:  P Aulenbacher; H G Manke; P Drings
Journal:  Klin Wochenschr       Date:  1987-05-15

4.  Lysis of small cell carcinoma of the lung tumor cell lines by gamma interferon-activated allogeneic peripheral blood mononuclear cells: abrogation of killing by pretreatment of tumor cells with gamma interferon.

Authors:  E D Ball; K E Nichols; O S Pettengill; G D Sorenson; M W Fanger
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GM1 antibody or anticancer agents.

Authors:  N Saijo; A Ozaki; Y Beppu; K Takahashi; J Fujita; Y Sasaki; H Nomori; M Kimata; E Shimizu; A Hoshi
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

6.  Suppression of natural killer activity in patients treated with cisplatin and methylprednisolone.

Authors:  K Takahashi; N Saijo; M Kimata; Y Sasaki; J Fujita; H Futami; E Shimizu; K Eguchi; T Shinkai; K Tominaga
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

7.  Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung.

Authors:  N Saijo; E Shimizu; M Shibuya; N Irimajiri; T Takizawa; K Eguchi; T Shinkai; K Tominaga; Z Shimabukuro; T Taniguchi; A Hoshi
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.